BDL-26722-08847
4 vaccinations
7 coded responses
50 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 782 / TX
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-01-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessFree text: Swollen lymph node in armpit of arm that received the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-24
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy, Muscle fatigue — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Swollen lymph node in groin, muscle fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-25
- 2021-01-26
-
2021-01-27
Survey response — day 7, dose 2MedDRA: Dyspnoea — Feeling: Fair · Joint pains, Fatigue or tirednessFree text: Shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-09-29
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Sensitive skin — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend schoolFree text: Skin sensitivityMedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Confusional state, Dizziness — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Dizziness, confusionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-03
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
- 2021-11-03
- 2021-11-11
- 2022-03-30
-
2022-09-29
Survey response — 12 months, dose 3MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-21
Dose 4 — Pfizer-BioNTech
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-24
-
2022-10-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-04
-
2023-01-20
Survey response — 3 months, dose 4MedDRA: Laryngitis — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
- 2023-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | No |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node in armpit of arm that received the vaccine
Systemic reaction (other): Swollen lymph node in groin, muscle fatigue
Release 2 — day 7, dose 2
Systemic reaction (other): Shortness of breath
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Skin sensitivity
Systemic reaction (other): Dizziness, confusion
Release 12 — 12 months, dose 3
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Laryngitis | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SRO | Confusional state | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Muscle fatigue | ✓ | ✓ | ✓ |
| SRO | Sensitive skin | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release